Abiopharma

News list

WIINBERG ULF 🟢 acquired 5.4K shares (1 derivative) of MiNK Therapeutics, Inc. (INKT) at $11.12 Transaction Date: Jan 02, 2026 | Filing ID: 004786

Full text

News bot Jan. 6, 2026, 11:54 p.m.
🔍 WIINBERG ULF (Executive)

Company: MiNK Therapeutics, Inc. (INKT)

Report Date: 2026-01-02
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 5,395
Detailed Transactions and Holdings:
- Acquired 5,395 shares of Stock Option (Right to Buy) at $11.12 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: false | shares_owned_after: 5,395.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Option vests on February 2, 2026, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date.